Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Retina > Standardized diagnosis of image-based diseases may be possible with federated learning
  • Retina

Standardized diagnosis of image-based diseases may be possible with federated learning

Ophthalmology 360

Federated learning, a method used to train machine learning models without sharing patient data, has the potential to standardize clinical diagnosis in retinopathy of prematurity (ROP), according to a study.

A deep learning (DL)-derived ROP vascular severity score (VSS) developed using federated learning found differences in the clinical diagnosis of plus disease, and overall levels of ROP severity between several institutions.

The deep learning model for plus disease classification was trained using only the clinical labels from retinal imaging from the neonatal intensive care units of 7 institutions which were labeled with the clinical diagnosis of plus disease (plus, pre-plus, no plus) and a reference standard diagnosis (RSD) provided by 3 image-based ROP graders and the clinical diagnosis.

A VSS was determined for each eye exam using the 3 class probabilities as well as an institutional VSS of averaged VSS values for high severity eyes at each exam for each institution.

Researchers found significant variations between institutions in the proportion of patients diagnosed with pre-plus disease.

Differences across institutions were observed in the institutional VSS and the level of vascular severity diagnosed as no plus. Researchers also observed a significant, inverse relationship between the institutional VSS and the mean gestational age (P = 0.049, adjusted R2=0.49).

Reference
Hanif A, Lu C, Chang K; Imaging and Informatics in Retinopathy of Prematurity Consortium. Federated learning for multi-center collaboration in ophthalmology: implications for clinical diagnosis and disease epidemiology. Ophthalmol Retina. 2022;S2468-6530(22)00104-X. doi: 10.1016/j.oret.2022.03.005. Epub ahead of print. PMID: 35304305.

Share

Related Content

  • Retina

Biosimilar aflibercept-ayyh demonstrates favorable real-world safety and efficacy

  • Retina

Switching to aflibercept 8 mg improved anatomical outcomes in previously treated nAMD

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency
  • Retina

Treat-and-extend aflibercept 8 mg improves outcomes in nAMD over 1 year

  • Retina

Intravitreal therapy in nAMD linked to lower depression and anxiety risk

  • Retina

Alternative aflibercept regimens maintained efficacy in wet AMD

  • Retina

Nanoscope Therapeutics is working on the potential first-ever optogenetic therapy for retinal diseases

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon